President Donald Trump announced on May 18, 2026, that the TrumpRx website will add over 600 generic and brand-name drugs, increasing the available medications nearly sevenfold since its launch in February 2026 [1, 2, 3, 4, 5, 6]. The announcement took place at a White House event and included new platform tools such as price comparison features, the ability to find the lowest-price nearby pharmacies, and home delivery options [1, 2].
TrumpRx is a government discount drug platform that connects consumers to online pharmacies and manufacturers offering discounted prescription drugs. It does not sell drugs directly [1, 2, 3, 4, 5, 6]. The service targets cash-paying, uninsured, or underinsured patients, a group seen as benefiting most from discounted prices [1, 2, 3, 4, 5, 6]. Trump said TrumpRx has been visited over 10 million times and has saved Americans more than $400 million so far [1, 2, 3, 4, 5, 6].
According to Trump, “TrumpRx will feature the best and lowest prices on prescriptions used by tens of millions of Americans already, and in some cases the discounted generics available through TrumpRx may be offered at an even lower cash price than the out of pocket insurance costs” [1]. He added that "By incorporating this massive catalog of low-cost generics at TrumpRx.gov consumers will now have one source to ensure that they're getting the lowest possible cost on their prescription, so they have a real option now today" [2]. Joe Gebbia, another platform partner, said, “Now you can compare for the best medicine prices, as easy as it is to compare hotels or Airbnbs or baseball tickets” [1].
Partners of the platform include Amazon Pharmacy, GoodRx, and Mark Cuban’s Cost Plus Drugs, which offers transparent pricing based on production cost plus fixed markup and fees. Mark Cuban, despite supporting the 2024 Democratic presidential candidate, has publicly backed TrumpRx efforts and integrated his Cost Plus Drugs platform with it. Cuban noted, “This platform has indeed saved a lot of money for patients undergoing IVF and other treatments” [2, 3, 4, 5, 6].
Critics, including experts and Democrats, say TrumpRx is limited in scope and that some brand-name drugs are more affordable under insurance. They also argue that existing services often offer lower prices than TrumpRx [1, 3, 4, 5, 6]. Boston University professor Rena Conti said, “Healthcare is really complicated in America, and even the supply of prescription drugs is really complicated in America. And this has added to the complexity, instead of reducing complexity” [1]. She added in Chinese that although TrumpRx adds many generics, actual savings depend highly on individual patient situations and most insured Americans usually pay less through insurance than with cash on TrumpRx [6].
The expansion of TrumpRx is part of a broader Republican strategy emphasizing affordability ahead of the 2026 midterm elections [7, 6].
